In recent months, we saw a Brazilian court rule on a decision allowing hemp cultivation, a first in the nation’s history. This, coupled with ANVISA’s recent policy announcements concerning its recognition of medicinal cannabis, represents a substantial and swift policy change in Latin America. I have previously written about the significance of the ANVISA announcement, but let’s look at the court decision in particular.

Hoban Law Group is very proud to have assisted in shaping the legal strategies employed by this group and others to prevail in Brazil, which is consistent with many of the decisions we’ve seen across other LatAm nations allowing for individuals to access cannabis for a variety of reasons. These decisions share a common theme: the UN Convention never intended to deprive people of the right to access plant-based medicines; nor did it intend to prevent people from cultivating plants that comprise a multitude of uses. This is especially true when considering the industrial hemp plant, and its very low levels of the psychotropic cannabinoid, tetrahydrocannabinol (THC).

Brazilian Court Allowing Hemp Cultivation

The court’s decision represents a momentous occasion. Farmers in one of the most populous countries in the world may now pursue a legal pathway to hemp cultivation. This will, once again, put industrial hemp, and its tens of thousands of uses on the center stage of sustainable economic solutions. A trend cannot be ignored.

Perhaps after far too long, policy makers and entire populations will begin to distinguish between psychoactive marijuana and non-psychoactive cáñamo. This is another grand step toward international recognition of hemp as a major global commodity. Full of hope, full of grace, is the human face. Call it home for you and me.

Bob Hoban